ADMAC CS LTD

Company number NI690848 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

ADMAC CS LTD - Analysis Report

Company Number: NI690848

Analysis Date: 2025-07-20 15:30 UTC

Financial Health Assessment for ADMAC CS LTD as of 30 September 2024


1. Financial Health Score: B

Explanation:
ADMAC CS LTD shows a notably improved financial position within its first two years of operation. From a negative net asset base of £72 in 2023, the company has grown to a positive net asset position of £12,201 in 2024. This demonstrates early signs of financial stability and healthy growth. The company’s micro entity status and small scale limit complexity, but the solid working capital and positive net assets indicate a generally sound financial condition. The absence of audit requirements and a low number of employees reflect its small scale, but the positive trajectory justifies a B grade rather than a top A, as it is still early in the business lifecycle and the absolute figures remain modest.


2. Key Vital Signs:

Metric 2024 Value Interpretation
Current Assets £18,039 Healthy cash and receivables base to cover short-term obligations.
Current Liabilities £4,638 Low short-term debts, indicating manageable creditor exposure.
Net Current Assets (Working Capital) £13,401 Strong positive working capital, a sign of liquidity health.
Net Assets (Shareholders Funds) £12,201 Positive equity after just two years, showing retained earnings and capital injection.
Average Employees 2 Small and manageable workforce consistent with micro entity status.
Account Category Micro Small scale business with simplified reporting, but limited financial history.

3. Diagnosis:

The company displays "healthy cash flow" and "robust working capital," which are crucial signs of a financially stable business. The significant turnaround from a negative net asset position in its first year to a positive balance indicates the business has successfully navigated the initial setup phase and is now in a growth or stabilisation phase. The modest current liabilities relative to current assets suggest no immediate liquidity distress or over-reliance on short-term debt. The presence of a single director who is also the sole shareholder provides clear governance but could pose concentration risk if not managed well.

The small size and limited operational history mean the company is vulnerable to market or operational shocks, but the signs so far point towards prudent financial management and a solid foundation.


4. Recommendations:

  • Maintain Strong Working Capital Management: Continue monitoring cash flow closely to preserve liquidity. Healthy working capital is the lifeblood of a small company and critical for meeting short-term obligations without stress.

  • Build Financial Reserves: Aim to retain some profits to grow reserves and buffer against future downturns or unexpected expenses. This will improve the "financial immune system."

  • Diversify Governance: Consider appointing additional directors or advisors to mitigate concentration risk and provide broader oversight and strategic input.

  • Prepare for Growth: With the company emerging from its start-up phase, review and formalise budgeting and forecasting processes to anticipate future capital needs and investment opportunities.

  • Stay Current with Filings: Continue to comply promptly with Companies House filing deadlines to avoid penalties and maintain confidence among stakeholders.

  • Explore Audit Thresholds: Although currently exempt, as the company grows, be prepared for the possibility of audit requirements and the need for more detailed financial controls.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.